Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease

NCT03596957 is registered in ClinicalTrials.gov with Lisbet Brandi as lead sponsor.

NCT NCT03596957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03596957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subacute Effect of Tolvaptan on Total Kidney Volume in Adult Patients With Autosomal Dominant Polycystic Kidney Disease
Lead sponsor
Lisbet Brandi
Phase
Phase 4
Overall status
Unknown status
Start date
September 12, 2018
Completion date
April 30, 2020
Enrollment
90 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney